Structure-activity relationship of estrogens: receptor affinity and estrogen antagonist activity of certain (E)- and (2)-1,2,3-triaryl-2-propen-2-ones
- 31 March 1985
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 28 (4) , 492-497
- https://doi.org/10.1021/jm00382a019
Abstract
The success of antiestrogen therapy in the treatment of certain hormone-responsive breast cancers has led to a resurgence of interest in the molecules which can prevent estrogens from exercising their full biochemical effects. (E)- and (Z)-1,2,3-triphenyl-2-propen-1-ones and some of their phenolic and alkoxy analogs, substituted at the p-position in one or more of the aromatic rings, with synthesized and assigned geometry on the basis of their spectroscopic data. The structure-activity relationship of the triarylpropenones was studied from the point of view of their estrogen receptor affinity and estrogen agonist and antagonist activities. (E)- as well as (Z)-propenones competed with estradiol for binding with the mouse uterine cytosol receptors, with phenolic analogs usually more potent than the unsubstituted as well as alkoxypropenones. The (E)-propenones, which have now emerged as a new group of estrogen receptor ligands, differed from Z isomers quite markedly in their binding specificities. The uterotrophic and antiuterotrophic assays in immature mice revealed that while some of the compounds were marginally estrogenic, nearly all the isomeric propenones were antiestrogenic to a varying degree.This publication has 11 references indexed in Scilit:
- Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterusMolecular and Cellular Endocrinology, 1982
- Antiestrogen basicity-activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogs of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (Tamoxifen, Nolvadex) having altered basicityJournal of Medicinal Chemistry, 1982
- Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifenThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Geometric Isomers of Substituted Triphenylethylenes and Antiestrogen ActionEndocrinology, 1981
- Differential interaction of antiestrogens with cytosol estrogen receptorsMolecular and Cellular Endocrinology, 1981
- Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and miceLife Sciences, 1980
- Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (.+-.)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]-1,2-propanediol and characterization and synthesis of a biologically important metaboliteJournal of Medicinal Chemistry, 1979
- Synthesis and antiestrogenic activity of [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methanone, methanesulfonic acid saltJournal of Medicinal Chemistry, 1979
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967
- Mammalian Antifertility Agents. IV. Basic 3,4-Dihydronaphthalenes and 1,2,3,4-Tetrahydro-1-naphtholsJournal of Medicinal Chemistry, 1967